MINI FUTURE SHORT - MERCK & CO. | Market Closed - Börse Stuttgart 01:14:37 18/05/2024 am IST | ||
| 5.47 EUR | 0.00% |
|
| Current month | -4.54% | ||
| 1 month | -10.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 5.47 | 0.00% |
| 16/24/16 | 5.47 | +1.30% |
| 15/24/15 | 5.4 | -5.10% |
| 14/24/14 | 5.69 | -0.35% |
| 13/24/13 | 5.71 | +2.70% |
Delayed Quote Börse Stuttgart
Last update May 18, 2024 at 01:14 am IST
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| WKN | PC7G1N |
| ISIN | DE000PC7G1N6 |
| Date issued | 28/03/2024 |
| Strike | 190.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.42 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.16 € |
|---|---|
| Lowest since issue | 5.31 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2
USD
Average target price
141.6
USD
Spread / Average Target
+7.96%
- Stock Market
- Certificates
- Certificat
